Pharmaceutical aspects of transdermal nitroglycerin

International Journal of Pharmaceutics

Volumn 135, Issue 1-2, 1996, Pages 1-11

  Hadgraft, Jonathan ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Nitroglycerin; Skin absorption; Transdermal drug delivery

Indexed keywords

ACRYLIC ACID; ADHESIVE AGENT; GLYCEROL DERIVATIVE; GLYCEROL LAURATE; GLYCERYL TRINITRATE; LACTOSE; OLEIC ACID ETHYL ESTER; POLYVINYL ALCOHOL; POVIDONE; SORBITAN OLEATE; SPM 751; UNCLASSIFIED DRUG;

ANGINA PECTORIS; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; DRUG TOLERANCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHARMACEUTICS; PRIORITY JOURNAL; REVIEW; SKIN ABSORPTION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030591405     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04475-4     Document Type: Review

References (15)

1. Bonn, R., Hadgraft, J. and Wolff, H.-M., Nitroglycerin TTS: biopharmaceutical and pharmacological aspects of transdermal therapy. In Rezakovic, D. and Alpert, J.S. (Eds.), Nitrate Therapy and Nitrate Tolerance: Current Concepts and Controversies, S. Karger AG, Basel, Switzerland, 1993, pp. 224-251.
2. Chu, L.C., Gale, R.M., Schmitt, L.G. and Shaw, J.E., Nitroglycerin concentrat ion in plasma - comparison between transdermal therapeutic system and ointment. Angiology, 35 (1984) 545-552.
3. Davis, A.F. and Hadgrap, J., Effect of supersaturation on membrane transport: 1, hydrocortisone acetate. Int. J. Pharm., 76 (1991) 1-8.
4. Denyer, S.P., Guy, R.H., Hadgraft, J. and Hugo, W.B., The microbial degradation of topically applied drugs. Int. J. Pharm., 26 (1985) 89-97.
5. Elkayam, U., Tolerance to organic nitrates evidence, mechanisms, clinical relevance, and strategies for prevention. Ann. Intern. Med., 114 (1991) 667-677.
6. Hadgraft, J., Beutner, D. and Wolff, H.M., In vivo-in vitro comparisons in the transdermal delivery of nitroglycerin. Int. J. Pharm., 89 (1993a) R1-R4.
7. Hadgraft, J., Lewis, D., Beutner, D. and Wolff, H.M., In vitro assessments of transdermal devices containing nitroglycerin. Int. J. Pharm., 73 (1991) 125-130.
8. Hadgraft, J., Wolff, H.M., Beutner, D. and Bonn, R., The delivery of nitroglycerin from a new acrylic type transdermal delivery system (SPM 751). In Brain, K.R., James, V.J. and Walters, K.A. (Eds.), Prediction of Percutaneous Penetration, Volume 3B, STS Publishing. Cardiff, 1993b, 551-553.
9. Hadgraft, J., Wolff, M., Bonn, R. and Cordes, G., Development of biphasic transdermal nitroglycerin delivery systems. Int. J. Pharm., 64 (1990) 187-194.
10. Karim, A., Transdermal absorption: a unique opportunity for constant delivery of nitroglycerin. Drug Dev. Ind. Pharm., 9 (1983) 671-689.
11. Noonan, P.K., Gonzalez, M.A., Ruggirello, D., Tomlinson, J., Babcock-Atkinson, E., Ray, M., Golub, A. and Cohen, A., Relative bioavailability of a new transdermal nitroglycerin delivery system. J. Pharm. Sci., 75 (1986) 688-691.
12. Shah, V.P., Tymes, N.W., Yamamoto, L.A. and Skelly, J.P., In vitro dissolution profile of transdermal nitroglycerin patches using paddle method. Int. J. Pharm., 32 (1986) 243-250.
13. Southwell, D., Barry, B.W. and Woodford, R., Variations in permeability of human skin within and between specimens. Int. J. Pharm., 18 (1984) 299-309.
14. Wester, R.C., Noonan, P.K., Smeach, S. and Kosobud, L. Pharmacokinetics and bioavailability of topical nitroglycerin in the rhesus monkey. Estimate of percutaneous first pass metabolism. J. Pharm. Sci., 72 (1983) 745-748.
15. Wolff, M., Cordes, G. and Luckow, V., In vitro and in vivo-release of nitroglycerin from a new transdermal therapeutic system. Pharm. Res., (1985) 23-29.